Human TRPC4 Virus-Like Particles

Transient receptor potential canonical 4 (TRPC4) is a member of the TRP ion channel superfamily, which plays a key role in cellular signaling by mediating calcium and sodium influx in response to various stimuli. TRPC4 is widely expressed in tissues such as the brain, heart, and vascular endothelium, where it participates in processes such as neurotransmitter release, regulation of vascular tone, and cell proliferation. TRPC4 can form homo- or heterotetrameric channels and often assembles with other TRPC subunits (such as TRPC1 or TRPC5) to modulate their functional properties. Dysregulation of TRPC4 has been linked to neurological disorders, cardiovascular diseases, and cancer, making it a promising therapeutic target.

TRPC4 virus-like particles (VLPs) are non-infectious, self-assembling nanostructures designed to mimic the conformation of native TRPC4 channels but without the presence of viral genetic material. These VLPs are typically produced by expressing the TRPC4 protein in recombinant systems, such as insect or mammalian cells, where they spontaneously form hollow, particle-like structures resembling the viral envelope. TRPC4 VLPs retain the antigenicity and structural features of the native channel, making them valuable for antibody production, vaccine development, and structural biology research. For example, they can serve as immunogens to generate high-affinity antibodies for diagnostic or therapeutic applications. Furthermore, their repetitive surface geometry enhances immune responses, making them potential vaccine candidates for TRPC4-related diseases. Beyond immunology, TRPC4 VLPs also facilitate cryo-electron microscopy (cryo-EM) studies to elucidate the three-dimensional structure of the channel, thereby facilitating the rational design of modulators.